MET: Difference between revisions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Expand stub to full MedTemplate parameter set |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 8: | Line 8: | ||
| starting_dose = | | starting_dose = | ||
| preparations = | | preparations = | ||
| fda_max = | |||
| routes = | | routes = | ||
| onset = | | onset = | ||
| Line 20: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-multi-route" author="erowid-claude" | |||
title="Multi-route dose ladders (Erowid, very tentative)"> | |||
Erowid's dosage documentation for MET<ref name="erowid-met-dose"> | |||
Erowid. MET Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/met/met_dose.shtml. | |||
Accessed 2026-05-25.</ref> is marked "very tentative" by Erowid, | |||
given limited reports. The following tiers are reported: | |||
'''Oral:''' | |||
* Light: 60-120 mg; Common: 80-150 mg; Strong: 150+ mg | |||
* (Threshold not characterized; timing not provided) | |||
'''Vaporized:''' | |||
* Threshold: ~8 mg; Light: 10-20 mg; Common: 15-30 mg; Strong: 30-40+ mg | |||
'''Insufflated:''' | |||
* Light: 10-20 mg; Common: 15-25 mg | |||
'''Intramuscular:''' | |||
* Common: 10-30 mg; Strong: 30-50+ mg | |||
The wide disparity between oral (60+ mg) and vaporized (8+ mg) tiers | |||
is a pharmacokinetic feature of the tryptamine class generally, and | |||
is particularly marked for MET. Erowid's own tentative qualification | |||
should be reflected in any presentation of these figures. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 31: | Line 57: | ||
}} | }} | ||
[[Category:Research chemicals]] | |||
[[Category:Tryptamines]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||
Latest revision as of 04:21, 26 May 2026
Research material, Tryptamine, Classic Psychedelic
MET
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
Multi-route dose ladders (Erowid, very tentative)0
Erowid's dosage documentation for MET[1] is marked "very tentative" by Erowid,
given limited reports. The following tiers are reported:
Oral:
- Light: 60-120 mg; Common: 80-150 mg; Strong: 150+ mg
- (Threshold not characterized; timing not provided)
Vaporized:
- Threshold: ~8 mg; Light: 10-20 mg; Common: 15-30 mg; Strong: 30-40+ mg
Insufflated:
- Light: 10-20 mg; Common: 15-25 mg
Intramuscular:
- Common: 10-30 mg; Strong: 30-50+ mg
The wide disparity between oral (60+ mg) and vaporized (8+ mg) tiers is a pharmacokinetic feature of the tryptamine class generally, and is particularly marked for MET. Erowid's own tentative qualification
should be reflected in any presentation of these figures.Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Research material, Tryptamine, Classic Psychedelic
Common uses
Pharmacy
Pharmacology
Purported mechanism
5-HT2A agonist
- ↑ Erowid. MET Dosage. Erowid.org. https://www.erowid.org/chemicals/met/met_dose.shtml. Accessed 2026-05-25.